Introduction of SOLIDEX®-ISOEx CD138+ Cell Isolation Solution

CD138+ Cells primarily refer to plasma cells, which are effector cells differentiated from B cells. These cells are found in the bone marrow, lymphoid tissues, and peripheral blood, and are responsible for antibody secretion (such as IgG, IgA). Plasma cells play a key role in adaptive immunity.

CD138 (also known as Syndecan-1) is a transmembrane glycoprotein specifically expressed on the surface of plasma cells and some epithelial cells, with particularly high expression in mature plasma cells. It is not found on early B cells or other blood cell types, providing highly specific expression. GeneMedi offers CD138 magnetic beads for the positive selection or depletion of CD138+ cells to meet various research and therapeutic needs.

Application Scenarios

Choose the Right CD138+ Plasma Cell Isolation Strategy for Your Research

CD138 (Syndecan-1) is commonly used as a marker for plasma cells and many multiple myeloma cells. In bone marrow samples, target plasma cells coexist with other hematopoietic cell populations, and the proportion of plasma cells can vary considerably between samples.

Enriching CD138+ cells before selected downstream assays can help increase the representation of target plasma cells in the sample. Depending on your research objectives, CD138+ cell isolation may be used as a preparation step for cytogenetic analysis, genomic studies, molecular profiling, or selected cellular assays. Alternatively, CD138+ cell depletion can be used when the remaining cell population is the focus of the study.

SOLIDEX®-ISOEx Human CD138 Isolation Solutions offer positive selection and CD138+ cell depletion options to support different research workflows.

Select Your Application

Choose an application below to explore how CD138+ cell isolation or depletion may fit into your experimental workflow.

FISH & Cytogenetic Analysis

Enrich CD138+ plasma cells before FISH analysis

Application overview

In multiple myeloma research, bone marrow samples contain a mixture of plasma cells and other hematopoietic cells. When plasma cells represent a relatively small proportion of the sample, analyzing unselected cells may reduce the representation of myeloma-associated cytogenetic abnormalities.

CD138+ plasma cell enrichment can be used before fluorescence in situ hybridization (FISH) to increase the representation of target plasma cells in the analyzed population. A published study reported that immunomagnetic CD138-positive cell sorting increased the proportion of abnormal cells identified by FISH compared with analysis without plasma cell purification.

How CD138+ isolation fits into the workflow
1Bone marrow sample preparation
2CD138+ plasma cell enrichment
3Downstream FISH preparation and analysis

Applications may include

  • Investigation of multiple myeloma-associated chromosomal abnormalities.
  • Cytogenetic studies of enriched plasma cell populations.
  • Research involving abnormalities such as t(4;14), t(11;14), t(14;16), 1q gain or amplification, and del(17p), depending on the selected FISH assay.

Key parameters to evaluate

  • CD138+ cell purity before and after isolation.
  • Number of target cells recovered.
  • Cell viability after isolation.
  • Compatibility of the enriched sample with the intended FISH workflow.
Product selection directionEvaluate CD138+ positive selection products according to your sample input, downstream assay requirements, and existing magnetic separation equipment. Compatibility with a specific separation column or instrument should be confirmed before use.

NGS & Genomic Analysis

Enrich target plasma cells for genomic and molecular studies

Application overview

In multiple myeloma research, genomic analysis may be affected by the presence of non-target cells in the starting sample. Enriching CD138+ plasma cells before nucleic acid preparation can help focus downstream analysis on the target cell population.

Published research has used CD138-enriched bone marrow plasma cells for genomic and copy-number analyses.

How CD138+ isolation fits into the workflow
1Bone marrow sample preparation
2CD138+ plasma cell enrichment
3Nucleic acid extraction and sample preparation
4NGS or genomic analysis

Potential research applications

  • Next-generation sequencing (NGS).
  • Genomic profiling and copy-number analysis.
  • Microarray-based genomic studies.
  • Other molecular analyses involving enriched plasma cell populations.

Key parameters to evaluate

  • Number of cells recovered after isolation.
  • CD138+ cell purity.
  • Nucleic acid yield and quality.
  • Compatibility with the input requirements of the selected analytical platform.
Product selection directionSelect a CD138+ isolation format based on the available cell input, target cell requirements, and downstream sample preparation workflow. Suitability for a particular sequencing or genomic assay should be evaluated under the relevant experimental conditions.

Transcriptomics & Proteomics

Study gene expression and molecular profiles in plasma cells

Application overview

Multiple myeloma cells exhibit molecular heterogeneity. Researchers may need to characterize gene expression, protein profiles, or differences between plasma cell populations.

CD138-based magnetic enrichment has been used in published studies involving single-cell RNA sequencing and proteomic analysis of plasma cell populations.

How CD138+ isolation fits into the workflow
1Bone marrow sample preparation
2CD138+ plasma cell enrichment
3Cell or molecular sample preparation
4Transcriptomic or proteomic analysis

Potential research applications

  • Bulk RNA sequencing (bulk RNA-seq).
  • Single-cell RNA sequencing (scRNA-seq).
  • Proteomic profiling.
  • Comparative molecular profiling of plasma cell populations.

Key parameters to evaluate

  • Cell recovery and viability.
  • Cell number and sample quality.
  • Nucleic acid or protein quality, as appropriate.
  • Potential effects of magnetic isolation on cell state or surface-marker detection.
Product selection directionIf your downstream assay depends on viable cells or specific cell-surface markers, evaluate whether the selected isolation format is appropriate for the intended analysis. For single-cell workflows, confirm that the isolated cells meet the input and quality requirements of the selected platform.

Ex Vivo Drug Response Studies

Enrich patient-derived myeloma cells for drug response research

Application overview

Researchers may use patient-derived multiple myeloma cells to investigate responses to individual compounds or drug combinations. Published research has incorporated CD138+ plasma cell enrichment into workflows for ex vivo drug sensitivity testing of patient-derived myeloma cells.

How CD138+ isolation fits into the workflow
1Bone marrow sample preparation
2CD138+ plasma cell enrichment
3Cell quality assessment
4Drug exposure and downstream analysis

Potential research applications

  • Exploratory drug sensitivity studies.
  • Evaluation of drug combinations.
  • Ex vivo cellular response assays.

Key parameters to evaluate

  • Number of target cells recovered.
  • Cell viability and condition before drug treatment.
  • Potential effects of the isolation procedure on downstream assay readouts.
  • Whether magnetic bead removal is required for the intended experiment.
Product selection directionFor applications that depend on cell viability or functional readouts, select the isolation format based on the downstream workflow and any requirements for bead removal. A releasable product may be considered when bead removal is important, but its suitability should be evaluated experimentally.
Important note: CD138+ enrichment does not, by itself, guarantee that isolated cells will retain their original phenotype or functional properties. These parameters should be verified for the intended assay.

CD138+ Cell Depletion

Remove CD138+ plasma cells to study the remaining bone marrow cell population

Application overview

Not every study aims to collect CD138+ plasma cells. In some experiments, the research objective is to investigate the remaining bone marrow cell population after plasma cell depletion.

Published studies have analyzed bone marrow cell populations after CD138+ cell depletion to investigate the cellular composition and immune microenvironment associated with multiple myeloma.

How CD138+ isolation fits into the workflow
1Bone marrow sample preparation
2CD138+ cell depletion
3Collection of the remaining cells
4Cellular, phenotypic, or molecular analysis

Potential research applications

  • Analysis of non-plasma-cell populations in bone marrow.
  • Investigation of the multiple myeloma-associated bone marrow microenvironment.
  • Characterization of the remaining cell population after CD138+ cell removal.

Key parameters to evaluate

  • Efficiency of CD138+ cell depletion.
  • Recovery of the remaining cell population.
  • Composition of the residual cell fraction.
  • Suitability of the depleted sample for downstream analysis.
Product selection directionConsider a SOLIDEX®-ISOEx CD138+ Cell Depletion product when the remaining cells, rather than the CD138+ target cells, are the primary subject of the study.
Important note: CD138+ cell depletion does not directly purify a specific non-CD138+ population, such as T cells or B cells. Additional isolation or characterization steps may be needed when a defined cell population is required.

Isolation method of SOLIDEX®-ISOEx CD138+ Cell Isolation Solution

  • Positive Selection
  • Depletion

Research Applications:

CD138 magnetic beads are used to isolate pure plasma cells, enhancing the sensitivity and reliability of techniques such as FISH (Fluorescence in situ hybridization), microarray genomic analysis, and genome sequencing. This is particularly useful in multiple myeloma research. The efficient pre-enrichment of plasma cells supports cytogenetic analysis of bone marrow samples, revealing chromosomal abnormalities or gene mutations.

Clinical Applications:

Positive selection of CD138+ plasma cells is used to study cell surface antigen expression in multiple myeloma, where the complete loss or insufficient expression of CD138 is associated with disease progression. This provides valuable insights for the optimization of diagnostic and therapeutic strategies.

Cat.NoProduct NameProducts Information
GM-Tg-hg-T13017-iso-nanoIMBSOLIDEX®-ISOEx Human CD138 Isolation Nanobeads (Column-based)Details
GM-Tg-hg-T13017-iso-nanoIMB-CFSOLIDEX®-ISOEx Human CD138 Isolation Nanobeads (Column-free)Details
GM-Tg-hg-T13017-iso-rel-kitSOLIDEX®-ISOEx Indirect Releasable Human CD138+ Cell Isolation Kit (Column-based)Details
GM-Tg-hg-T13017-iso-rel-kit-CFSOLIDEX®-ISOEx Indirect Releasable Human CD138+ Cell Isolation Kit (Column-free)Details
GM-Tg-hg-T13017-iso-kitSOLIDEX®-ISOEx Indirect Human CD138+ Cell Isolation Kit (Column-based)Details
GM-Tg-hg-T13017-iso-kit-CFSOLIDEX®-ISOEx Indirect Human CD138+ Cell Isolation Kit (Column-free)Details

Removal of CD138+ cells from PBMCs or bone marrow to obtain pure T cells or early B cells, for use in B cell differentiation studies or the development of immunotherapies.

Cat.NoProduct NameProducts Information
GM-Tg-hg-T13017-dep-nanoIMBSOLIDEX®-ISOEx Human CD138+ Cell Depletion Nanobeads (Column-based)Details
GM-Tg-hg-T13017-dep-kitSOLIDEX®-ISOEx Indirect Human CD138+ Cell Depletion Kit (Column-based)Details

Performance Validation

CD138+ cell isolation validation by flow cytometry

Figure. Efficient isolation of CD138+ cells from a mixture of human PBMCs and U266 cells using SOLIDEX®-ISOEx Human CD138 Isolation Nanobeads (Column-Based). Cells were stained with APC-conjugated anti-CD138 antibody and analyzed by flow cytometry; histograms show the RL1-H::APC-H channel and the values indicate the percentage of CD138+ cells within the gate. CD138+ cells were 4.72% before isolation, 93.4% after isolation with Company M nanobeads and 94.6% after isolation with SOLIDEX®-ISOEx CD138 Nanobeads.

Find a Suitable CD138+ Cell Isolation Solution

Are you optimizing a plasma cell isolation workflow or evaluating a CD138+ enrichment method for your downstream research?

Share your sample type, approximate starting cell number, downstream application, and existing magnetic separation equipment with us. Our team can help you assess the appropriate SOLIDEX®-ISOEx CD138 product format for your experimental needs.

FAQ

What are SOLIDEX®-ISOEx Human CD138 Isolation Solutions designed for?

SOLIDEX®-ISOEx Human CD138 Isolation Solutions are designed to enrich CD138-expressing cells or deplete CD138+ cells from human samples. They are particularly suitable for plasma cell enrichment in multiple myeloma research and can be evaluated for downstream applications such as FISH, NGS, genomic analysis, and selected cellular studies.

The appropriate product should be selected according to the sample type, downstream application, and required isolation format.

Which sample types can be used for CD138+ cell isolation?

Human bone marrow is an important sample type for CD138+ plasma cell enrichment, particularly in multiple myeloma research. Depending on the intended application and product specifications, PBMCs and lymphoid tissues may also be considered.

Sample quality, target cell abundance, and sample preparation conditions can affect isolation performance. Please refer to the Instructions for Use (IFU) of the selected product to confirm its suitability for your sample type.

What is the difference between CD138+ positive selection and CD138+ cell depletion?

CD138+ Positive Selection is designed to enrich and collect the CD138-expressing target cell population for downstream analysis.

CD138+ Cell Depletion is designed to remove CD138-expressing cells so that the remaining cell population can be collected for further research.

Choose positive selection when your primary objective is to obtain CD138+ plasma cells. Choose cell depletion when your research focuses on the remaining cell population, such as non-plasma-cell components of bone marrow.

Please note that CD138+ cell depletion does not directly purify a specific non-CD138+ cell type.

What is the difference between column-based and column-free CD138 isolation products?

Column-based products use a magnetic separation column as part of the isolation workflow.

Column-free products are designed for workflows that do not require a separation column. However, a suitable magnetic separation device may still be required, depending on the product instructions.

The choice depends on your existing equipment, preferred workflow, sample input, and the operating requirements of the selected product. Column-free does not necessarily mean equipment-free.

What is the difference between direct CD138 nanobeads and indirect CD138 isolation kits?

Direct CD138 isolation nanobeads recognize and bind target cells through a CD138-specific binding component associated with the magnetic beads.

Indirect CD138 isolation kits first use a biotinylated anti-CD138 antibody to label the target cells, followed by anti-biotin magnetic nanobeads for magnetic separation.

The two formats differ mainly in their cell-labeling strategies and product components. Please refer to the specifications and IFU of each product to determine which format best fits your experimental workflow.

Should I choose a releasable or non-releasable CD138 isolation product?

The choice depends on whether magnetic bead removal is required for your downstream application.

Releasable products are designed to allow magnetic bead removal using the supplied dissociation buffer and the prescribed procedure. They may be considered for applications in which bead removal is desired before subsequent analysis or cell-based experiments.

Non-releasable products are designed for workflows in which magnetic bead release is not required.

For applications involving cell culture, functional assays, or cell-surface marker analysis, consider whether bead removal is necessary and evaluate the potential effects of the isolation procedure on your downstream results.

Are SOLIDEX®-ISOEx CD138 products compatible with Miltenyi OctoMACS and MS Columns?

Yes. SOLIDEX®-ISOEx CD138 magnetic bead products are compatible with commonly used magnetic separation systems and related separation consumables available on the market, including products from Miltenyi.

If you currently use a Miltenyi OctoMACS separator with MS Columns, you can continue using your existing equipment and compatible separation columns with the appropriate SOLIDEX®-ISOEx CD138 products. There is no need to purchase additional magnetic separation equipment solely to use GeneMedi magnetic beads.

For product-specific operating instructions and conditions, please refer to the corresponding IFU. You are also welcome to contact our technical support team for further assistance.

Can CD138-enriched cells be used for FISH, NGS, and other downstream analyses?

CD138+ cell enrichment can be used as a sample preparation step for selected downstream applications, including FISH and genomic studies. However, the suitability of isolated cells depends on the requirements of the specific analytical method.

For FISH or NGS workflows, consider target cell purity, recovered cell number, sample quality, and downstream sample preparation requirements.

For cell culture or functional assays, additional considerations may include cell viability, magnetic bead removal requirements, and potential effects of the isolation procedure on cell phenotype or function.

We recommend validating the suitability of isolated cells under your intended experimental conditions.

Are product documentation and technical support available?

 




<